Stephen Dale, M.D.
Former Chief Medical OfficeratKura Oncology· In proxies 2021–2024
Pay in FY2024Kura Oncology stock -39.4% the same year
Stephen Dale, M.D. was paid $2.5M in FY2024 (Dec). Kura Oncology stock fell 39.4% that year.
Pay$100 in the stock at the end of FY20 → $23
Experience
- Kura OncologyPublic company · 5 yr
- Former Chief Medical Officer2021 – Present · 5 yrStock in role -70%
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?